SK285190B6 - Kryštálová modifikácia proti plesniam a farmaceutický prostriedok s jej obsahom - Google Patents

Kryštálová modifikácia proti plesniam a farmaceutický prostriedok s jej obsahom Download PDF

Info

Publication number
SK285190B6
SK285190B6 SK512-2000A SK5122000A SK285190B6 SK 285190 B6 SK285190 B6 SK 285190B6 SK 5122000 A SK5122000 A SK 5122000A SK 285190 B6 SK285190 B6 SK 285190B6
Authority
SK
Slovakia
Prior art keywords
vwd
crystal modification
triazol
weak
modification
Prior art date
Application number
SK512-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK5122000A3 (en
Inventor
David R. Andrews
William Leong
Anantha R. Sudhakar
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK5122000A3 publication Critical patent/SK5122000A3/sk
Publication of SK285190B6 publication Critical patent/SK285190B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK512-2000A 1997-10-07 1998-10-05 Kryštálová modifikácia proti plesniam a farmaceutický prostriedok s jej obsahom SK285190B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07
PCT/US1998/020476 WO1999018097A1 (fr) 1997-10-07 1998-10-05 Olymorphe antifongique cristallin

Publications (2)

Publication Number Publication Date
SK5122000A3 SK5122000A3 (en) 2000-09-12
SK285190B6 true SK285190B6 (sk) 2006-08-03

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
SK512-2000A SK285190B6 (sk) 1997-10-07 1998-10-05 Kryštálová modifikácia proti plesniam a farmaceutický prostriedok s jej obsahom

Country Status (31)

Country Link
EP (1) EP1021439B1 (fr)
JP (4) JP2001519346A (fr)
KR (1) KR100626109B1 (fr)
CN (1) CN1125067C (fr)
AR (1) AR015947A1 (fr)
AT (1) ATE263163T1 (fr)
AU (1) AU759982B2 (fr)
BR (1) BR9812866A (fr)
CA (1) CA2305803C (fr)
CO (1) CO4970829A1 (fr)
CZ (1) CZ299835B6 (fr)
DE (1) DE69822859T2 (fr)
DK (1) DK1021439T3 (fr)
ES (1) ES2217594T3 (fr)
HK (1) HK1029588A1 (fr)
HU (1) HU225233B1 (fr)
ID (1) ID29290A (fr)
IL (1) IL135331A (fr)
IN (1) IN1998CH02232A (fr)
MX (1) MX225999B (fr)
MY (1) MY130126A (fr)
NO (1) NO318827B1 (fr)
NZ (1) NZ503662A (fr)
PE (1) PE120499A1 (fr)
PH (1) PH11998002606B1 (fr)
PL (1) PL189317B1 (fr)
PT (1) PT1021439E (fr)
SK (1) SK285190B6 (fr)
TW (1) TW589310B (fr)
WO (1) WO1999018097A1 (fr)
ZA (1) ZA989063B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (fr) * 2008-06-02 2009-12-09 Sandoz AG Compositions pharmaceutiques contenant une forme cristalline du posaconazole
EP2141159A1 (fr) 2008-07-03 2010-01-06 Sandoz AG Formule cristalline de posaconazole
EP2451805A1 (fr) 2009-07-09 2012-05-16 Sandoz AG Forme cristalline du posaconazole
RU2585683C2 (ru) 2010-05-19 2016-06-10 Сандоз Аг Очистка позаконазола и промежуточных продуктов для синтеза позаконазола
EP2571847B1 (fr) 2010-05-19 2016-09-21 Sandoz AG Procédé de préparation de hydrazides chiraux
RU2580318C2 (ru) 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
CN102906087B (zh) 2010-05-19 2016-03-23 桑多斯股份公司 制备手性三唑酮的方法
CA2838051C (fr) 2011-06-16 2019-09-24 Sandoz Ag Procede pour la preparation d'un compose chiral
EP2758385B1 (fr) * 2011-09-19 2018-03-28 MSN Laboratories Limited Procédé pour la préparation de médicament antifongique triazole, ses intermédiaires et polymorphes de celui-ci
EP3024828B1 (fr) * 2013-07-25 2017-05-17 Sandoz AG Procédé amélioré de préparation de la forme cristalline iv de posaconazole
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
RS60737B1 (sr) 2014-10-21 2020-09-30 Ariad Pharma Inc Kristalni oblici 5-hloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
WO2017025292A1 (fr) 2015-08-08 2017-02-16 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Formulation gastro-résistante contenant du posaconazole
WO2017111179A1 (fr) 2015-12-24 2017-06-29 Takeda Pharmaceutical Company Limited Cocristal, procédé de production associé et médicament contenant le cocristal
EP3210599B1 (fr) 2016-02-26 2024-08-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Formulation gastro-résistante contenant du posaconazole et un inhibiteur de précipitation polymère
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (fr) 2016-07-08 2017-03-02 Synthon B.V. Composition pharmaceutique comprenant du posaconazole amorphe
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
US20240293399A1 (en) 2020-08-13 2024-09-05 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
WO2023012378A1 (fr) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules contenant du posaconazole
EP4091604B1 (fr) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules contenant du posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
PL181193B1 (pl) * 1993-12-21 2001-06-29 Schering Corp Nowe pochodne tetrahydrofuranowe o działaniu przeciwgrzybicznym, kompozycja farmaceutyczna do leczenia infekcji grzybiczych oraz sposób wytwarzania tych związków
AU688455B2 (en) * 1994-01-24 1998-03-12 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
ES2199291T3 (es) * 1995-06-02 2004-02-16 Schering Corporation Antifungicos de tetrahidrofurano.

Also Published As

Publication number Publication date
CN1281449A (zh) 2001-01-24
HUP0004899A2 (hu) 2002-02-28
ID29290A (id) 2001-08-16
EP1021439B1 (fr) 2004-03-31
DE69822859T2 (de) 2005-01-27
DK1021439T3 (da) 2004-05-10
MXPA00003404A (es) 2000-11-01
DE69822859D1 (de) 2004-05-06
AR015947A1 (es) 2001-05-30
KR100626109B1 (ko) 2006-09-20
JP2012153729A (ja) 2012-08-16
ATE263163T1 (de) 2004-04-15
CA2305803A1 (fr) 1999-04-15
CZ299835B6 (cs) 2008-12-10
ZA989063B (en) 1999-04-06
MY130126A (en) 2007-06-29
IL135331A (en) 2005-08-31
SK5122000A3 (en) 2000-09-12
PE120499A1 (es) 1999-12-04
CN1125067C (zh) 2003-10-22
AU759982B2 (en) 2003-05-01
NZ503662A (en) 2002-10-25
CO4970829A1 (es) 2000-11-07
JP2008106075A (ja) 2008-05-08
WO1999018097A1 (fr) 1999-04-15
EP1021439A1 (fr) 2000-07-26
PT1021439E (pt) 2004-07-30
TW589310B (en) 2004-06-01
ES2217594T3 (es) 2004-11-01
HU225233B1 (en) 2006-08-28
HK1029588A1 (en) 2001-04-06
BR9812866A (pt) 2000-08-08
JP2001519346A (ja) 2001-10-23
PL339659A1 (en) 2001-01-02
NO20001779L (no) 2000-06-06
IN1998CH02232A (fr) 2005-03-04
CA2305803C (fr) 2009-12-22
JP2012153730A (ja) 2012-08-16
KR20010030959A (ko) 2001-04-16
HUP0004899A3 (en) 2002-03-28
IL135331A0 (en) 2001-05-20
AU9780398A (en) 1999-04-27
PL189317B1 (pl) 2005-07-29
PH11998002606B1 (en) 2006-08-10
CZ20001264A3 (cs) 2000-08-16
MX225999B (es) 2005-02-02
NO20001779D0 (no) 2000-04-06
NO318827B1 (no) 2005-05-09

Similar Documents

Publication Publication Date Title
SK285190B6 (sk) Kryštálová modifikácia proti plesniam a farmaceutický prostriedok s jej obsahom
US6958337B2 (en) Crystalline antifungal polymorph
MX2008002541A (es) Formas de cristal delta y epsilon de mesilato de imatinib.
SK14832000A3 (sk) Kryštalické formy 5,6-dichlór-2-(izopropylamino)-1-(beta-l- ribofuranozyl)-1h-benzimidazolu, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
CA2550726A1 (fr) Procedes de preparation de formes cristallines d'aripiprazole
RU2198167C2 (ru) Кристаллические модификации 1-(2,6-дифторбензил)-1н-1,2,3-триазол-4-карбоксамида и фармацевтическая композиция
EP0010361B1 (fr) Bis-imidazoles, leur préparation et compositions pharmaceutiques les contenant
JPS59206360A (ja) 抗ウイルス剤
ZA200500372B (en) Novel salt and polymorphs of desloratadine hemifumarate
HU195502B (en) Process for producing triazol derivatives of fungicide activity and pharmaceutical compositions containing them
SK283735B6 (sk) Forma VI 5,6-dichlór-2-(izopropylamino)-1-(beta-L-ribofuranozyl)- 1H-benzimidazolu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
JPS6030290B2 (ja) 製薬組成物及び使用
US6335347B1 (en) Ethyl 4-(8-chloro-5,6-dihydro-11 H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidene carboxylate polymorph
SK281688B6 (sk) Regioselektívny spôsob prípravy derivátov 1-(1,2,4-triazol-1-yl)-propan-2-olu
CZ20013866A3 (cs) Antifungální ethery
WO1999018111A1 (fr) Polymorphe antifongique cristallin d'ester de glycine
CZ12566U1 (cs) Amlodipinhemimaleát a farmaceutický prostředek

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20121108

MK4A Expiry of patent

Expiry date: 20181005